Year |
Citation |
Score |
Low-probability matches (unlikely to be authored by this person) |
2024 |
Hacker B, Imms P, Dharani AM, Zhu J, Chowdhury NF, Chaudhari NN, Irimia A. Identification and connectomic profiling of concussion using Bayesian machine learning. Journal of Neurotrauma. PMID 38482793 DOI: 10.1089/neu.2023.0509 |
0.01 |
|
2023 |
Maleddu A, Zhu J, Clay MR, Wilky BA. Current therapies and future prospective for locally aggressive mesenchymal tumors. Frontiers in Oncology. 13: 1160239. PMID 37546427 DOI: 10.3389/fonc.2023.1160239 |
0.01 |
|
2021 |
Quintiliani LM, Whiteley JA, Zhu J, Quinn EK, Murillo J, Lara R, Kane J. Examination of Food Insecurity, Socio-Demographic, Psychosocial, and Physical Factors among Residents in Public Housing. Ethnicity & Disease. 31: 159-164. PMID 33519166 DOI: 10.18865/ed.31.1.159 |
0.01 |
|
2019 |
Zhu J, Frech T. Gut disease in systemic sclerosis - new approaches to common problems. Current Treatment Options in Rheumatology. 5: 11-19. PMID 31750073 DOI: 10.1007/s40674-019-00117-x |
0.01 |
|
2016 |
Wang W, Li Y, Zhu JY, Fang D, Ding HF, Dong Z, Jing Q, Su SB, Huang S. Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition. Oncotarget. PMID 27901486 DOI: 10.18632/Oncotarget.13601 |
0.01 |
|
2012 |
Liu C, Kuei C, Zhu J, Yu J, Zhang L, Shih A, Mirzadegan T, Shelton J, Sutton S, Connelly MA, Lee G, Carruthers N, Wu J, Lovenberg TW. 3,5-Dihydroxybenzoic acid, a specific agonist for hydroxycarboxylic acid 1, inhibits lipolysis in adipocytes. The Journal of Pharmacology and Experimental Therapeutics. 341: 794-801. PMID 22434674 DOI: 10.1124/Jpet.112.192799 |
0.01 |
|
2011 |
Kuei C, Yu J, Zhu J, Wu J, Zhang L, Shih A, Mirzadegan T, Lovenberg T, Liu C. Study of GPR81, the lactate receptor, from distant species identifies residues and motifs critical for GPR81 functions. Molecular Pharmacology. 80: 848-58. PMID 21862690 DOI: 10.1124/Mol.111.074500 |
0.01 |
|
2010 |
Nepomuceno D, Sutton S, Yu J, Zhu J, Liu C, Lovenberg T, Bonaventure P. Mutagenesis studies of neuropeptide S identify a suitable peptide tracer for neuropeptide S receptor binding studies and peptides selectively activating the I(107) variant of human neuropeptide S receptor. European Journal of Pharmacology. 635: 27-33. PMID 20307531 DOI: 10.1016/j.ejphar.2010.03.008 |
0.01 |
|
2009 |
Liu C, Kuei C, Sutton S, Shelton J, Zhu J, Nepomuceno D, Hossain MA, Wade JD, Bathgate RA, Bonaventure P, Lovenberg T. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7. Annals of the New York Academy of Sciences. 1160: 31-7. PMID 19416155 DOI: 10.1111/j.1749-6632.2008.03790.x |
0.01 |
|
2009 |
Liu C, Wu J, Zhu J, Kuei C, Yu J, Shelton J, Sutton SW, Li X, Yun SJ, Mirzadegan T, Mazur C, Kamme F, Lovenberg TW. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. The Journal of Biological Chemistry. 284: 2811-22. PMID 19047060 DOI: 10.1074/jbc.M806409200 |
0.01 |
|
2008 |
Zhu J, Kuei C, Sutton S, Kamme F, Yu J, Bonaventure P, Atack J, Lovenberg TW, Liu C. Identification of the domains in RXFP4 (GPCR142) responsible for the high affinity binding and agonistic activity of INSL5 at RXFP4 compared to RXFP3 (GPCR135). European Journal of Pharmacology. 590: 43-52. PMID 18582868 DOI: 10.1016/j.ejphar.2008.05.025 |
0.01 |
|
2007 |
Kuei C, Sutton S, Bonaventure P, Pudiak C, Shelton J, Zhu J, Nepomuceno D, Wu J, Chen J, Kamme F, Seierstad M, Hack MD, Bathgate RA, Hossain MA, Wade JD, et al. R3(BDelta23 27)R/I5 chimeric peptide, a selective antagonist for GPCR135 and GPCR142 over relaxin receptor LGR7: in vitro and in vivo characterization. The Journal of Biological Chemistry. 282: 25425-35. PMID 17606621 DOI: 10.1074/jbc.M701416200 |
0.01 |
|
2005 |
Sutton SW, Bonaventure P, Kuei C, Nepomuceno D, Wu J, Zhu J, Lovenberg TW, Liu C. G-protein-coupled receptor (GPCR)-142 does not contribute to relaxin-3 binding in the mouse brain: further support that relaxin-3 is the physiological ligand for GPCR135. Neuroendocrinology. 82: 139-50. PMID 16679775 DOI: 10.1159/000091267 |
0.01 |
|
2005 |
Liu C, Kuei C, Sutton S, Chen J, Bonaventure P, Wu J, Nepomuceno D, Kamme F, Tran DT, Zhu J, Wilkinson T, Bathgate R, Eriste E, Sillard R, Lovenberg TW. INSL5 is a high affinity specific agonist for GPCR142 (GPR100). The Journal of Biological Chemistry. 280: 292-300. PMID 15525639 DOI: 10.1074/jbc.M409916200 |
0.01 |
|
2004 |
Peterson KS, Huang JF, Zhu J, D'Agati V, Liu X, Miller N, Erlander MG, Jackson MR, Winchester RJ. Characterization of heterogeneity in the molecular pathogenesis of lupus nephritis from transcriptional profiles of laser-captured glomeruli. The Journal of Clinical Investigation. 113: 1722-33. PMID 15199407 DOI: 10.1172/JCI19139 |
0.01 |
|
2004 |
Kamme F, Zhu J, Luo L, Yu J, Tran DT, Meurers B, Bittner A, Westlund K, Carlton S, Wan J. Single-cell laser-capture microdissection and RNA amplification. Methods in Molecular Medicine. 99: 215-23. PMID 15131340 DOI: 10.1385/1-59259-770-X:215 |
0.01 |
|
2003 |
Kamme F, Salunga R, Yu J, Tran DT, Zhu J, Luo L, Bittner A, Guo HQ, Miller N, Wan J, Erlander M. Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 23: 3607-15. PMID 12736331 |
0.01 |
|
Hide low-probability matches. |